BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leal L, Fehér C, Richart V, Torres B, García F. Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response. Vaccines (Basel) 2020;8:E442. [PMID: 32764508 DOI: 10.3390/vaccines8030442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Cafaro A, Ensoli B. HIV-1 therapeutic vaccines in clinical development to intensify or replace antiretroviral therapy: the promising results of the Tat vaccine. Expert Rev Vaccines 2022;:1-11. [PMID: 35695268 DOI: 10.1080/14760584.2022.2089119] [Reference Citation Analysis]
2 van Paassen P, Dijkstra M, Peay HL, Rokx C, Verbon A, Reiss P, Prins JM, Henderson GE, Rennie S, Nieuwkerk PT, de Bree GJ. Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infection. J Virus Erad 2022;8:100072. [PMID: 35769632 DOI: 10.1016/j.jve.2022.100072] [Reference Citation Analysis]
3 Espinar-Buitrago M, Muñoz-Fernández MA. New Approaches to Dendritic Cell-Based Therapeutic Vaccines Against HIV-1 Infection. Front Immunol 2021;12:719664. [PMID: 35058917 DOI: 10.3389/fimmu.2021.719664] [Reference Citation Analysis]
4 Vignoles M, Andrade V, Noguera M, Brander C, Mavian C, Salemi M, Paredes R, Sharkey M, Stevenson M. Persistent HIV-1 transcription in CD4+ T cells from ART-suppressed individuals can originate from biologically competent proviruses. J Virus Erad 2021;7:100053. [PMID: 34621530 DOI: 10.1016/j.jve.2021.100053] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Zheng L, Tierney C, Bosch RJ. Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations. Curr HIV/AIDS Rep 2021. [PMID: 34213731 DOI: 10.1007/s11904-021-00569-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Sun Y, Li H, Luo G, Meng X, Guo W, Fitzpatrick T, Ao Y, Feng A, Liang B, Zhan Y, Sande A, Xie F, Wang Y, Qian HZ, Cai Y, Zou H. Antiretroviral treatment interruption among people living with HIV during COVID-19 outbreak in China: a nationwide cross-sectional study. J Int AIDS Soc 2020;23:e25637. [PMID: 33247541 DOI: 10.1002/jia2.25637] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]